Meta‐analysis of recombinant FSH and urinary‐derived gonadotrophins for IVF or ICSI

By Al‐Inany Hesham  

Human Reproduction, Vol. 18, Iss. 7, 2003-07 ,pp. : 1555-1556

Oxford University Press

Access to resources Recommend Favorite

Pregnancy and obstetrics. Meta-analysis on recombinant versus urinary follicle stimulating hormone

By  

Human Reproduction, Vol. 15, Iss. 7, 2000-07 ,pp. : 1650-1651

Oxford University Press

Access to resources Recommend Favorite

Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis

By Coomarasamy Arri   Afnan Masoud   Cheema Deepti   van der Veen Fulco   Bossuyt Patrick M.M.   van Wely Madelon  

Human Reproduction, Vol. 23, Iss. 2, 2008-02 ,pp. : 310-315

Oxford University Press

Access to resources Recommend Favorite

Cost-effectiveness of recombinant follicle-stimulating hormone (FSH) versus human FSH in intrauterine insemination cycles: A statistical model-derived analysis

By Gerli Sandro   Bini Vittorio   Renzo Gian Carlo Di  

Gynecological Endocrinology, Vol. 24, Iss. 1, 2008-01 ,pp. : 18-23

Informa Healthcare

Access to resources Recommend Favorite

Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins?

By Reichl H.  

Human Reproduction, Vol. 17, Iss. 10, 2002-10 ,pp. : 2501-2508

Oxford University Press

Access to resources Recommend Favorite